KFO
Kopp Family Office Portfolio holdings
AUM
$155M
This Quarter Return
+48.44%
1 Year Return
+12.37%
3 Year Return
+32.09%
5 Year Return
+62.77%
10 Year Return
–
AUM
$157M
AUM Growth
–
Cap. Flow
+$157M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
NeoGenomics
NEO
|
$142M |
| 2 |
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
|
$10.2M |
| 3 |
FIVE9
FIVN
|
$1.87M |
| 4 |
XENT
Intersect ENT, Inc
XENT
|
$1.87M |
| 5 |
Vericel Corp
VCEL
|
$1.74M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 97.62% |
| 2 | Technology | 1.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NeoGenomics
NEO
$1.13B
| $142M | 90.06% |
+4,844,625
| New | +$142M |
|
|
SRGA
2
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $10.2M | 6.46% |
+3,709,829
| New | +$10.2M |
|
|
3
FIVE9
FIVN
$2.08B
| $1.87M | 1.19% |
+28,550
| New | +$1.87M |
|
|
XENT
4
DELISTED
Intersect ENT, Inc
XENT
| $1.87M | 1.19% |
+75,000
| New | +$1.87M |
|
|
5
Vericel Corp
VCEL
$1.83B
| $1.74M | 1.1% |
+99,800
| New | +$1.74M |
|